Email Alert RSS
Volume 13 Issue 2
Mar.  2022
Turn off MathJax
Article Contents
Article Navigation >  Medical Journal of Peking Union Medical College Hospital  > 2022  >  13(2): 203-226
Acquired Immunodeficiency Syndrome and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 203-226. doi: 10.12290/xhyxzz.2022-0097
Citation: Acquired Immunodeficiency Syndrome and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 203-226. doi: 10.12290/xhyxzz.2022-0097
shu

Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)

doi: 10.12290/xhyxzz.2022-0097
Funds:

Major National Science and Technology Projects in the 13th Five Year Plan 2017ZX10202101

More Information

    Corresponding author: LI Taisheng, E-mail: litsh@263.net
    Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

  • Received Date: 2022-03-02
  • Accepted Date: 2022-03-03
    • Available Online: 2022-03-15
  • Publish Date: 2022-03-30
    Abstract
  • In 2005, the first edition of the guidelines for the diagnosis and treatment of acquired immunodeficiency syndrome(AIDS) was formulated by the AIDS Professional Group of the Society of Infectious Diseases of Chinese Medical Association, which was updated in 2011, 2015, and 2018, respectively. The 2021 edition of the guidelines was revised on the basis of the fourth edition and updated according to the national clinical practice and the latest research results. The new research progress in opportunistic infections, antiretroviral therapy, post-exposure prophylaxis (PEP), pre-exposure prophylaxis (PrEP), the whole course of the management of HIV infection, and prevention of mother to child transmission was updated in these guidelines. In the 2021 edition, the indications, medication regimen, follow-up and monitoring, and precautions of PrEP are introduced in detail. This edition of guidelines will be updated regularly according to the latest clinical evidence.
    • FullText(HTML)
  • loading
    • References(63)
  • [1] 中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防与控制中心. 中国艾滋病诊疗指南(2018版)[J]. 协和医学杂志, 2018, 9: 31-52. doi:  10.3969/j.issn.1674-9081.2019.01.006
    [2] World Health Organization. HIV/AIDS[EB/OL]. (2021-07-17)[2021-10-30]. https://www.who.int/news-room/fact-sheets/detail/hiv-aids.
    [3] United Nations. Political declaration on HIV and AIDS: ending inequalities and getting on track to end AIDS by 2030[EB/OL]. (2021-06-09)[2021-10-30]. https://undocs.org/A/RES/75/284.
    [4] 梁焱铃, 冯毅, 邵一鸣. HIV-1 C亚型、CRF07_BC和CRF08_BC重组毒株的起源和分子流行病学研究进展[J]. 中国艾滋病性病, 2021, 27: 549-552. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA202105036.htm
    [5] 钟平. HIV分子流行病学研究和实践进展[J]. 新发传染病电子杂志, 2019, 4: 137-144. https://www.cnki.com.cn/Article/CJFDTOTAL-XFCR201903004.htm
    [6] 粟斌, 吴昊, 张彤. HIV-2型感染流行病学诊疗方案及防控策略[J]. 中国艾滋病性病, 2019, 25: 756-759. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA201907032.htm
    [7] 中国疾病预防控制中心. 全国艾滋病检测技术规范(2020年修订版)[EB/OL]. (2020-05-18)[2021-10-30]. http://ncaids.chinacdc.cn/zxzx/zxdteff/202005/W020200522484711502629.pdf.
    [8] 荆凡辉, 吕玮, 李太生. HIV感染者免疫功能重建新视角: CD4/CD8比值[J]. 中国艾滋病性病, 2018, 24: 643-646. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA201806032.htm
    [9] Li Y, Han Y, Xie J, et al. CRF01_ AE subtype is associated with X4 tropism and fast HIV progression in Chinese patients infected through sexual transmission[J]. AIDS, 2014, 28: 521-530. doi:  10.1097/QAD.0000000000000125
    [10] Su B, Dispinseri S, Iannone V, et al. Update on Fc-mediated antibody functions against HIV-1 beyond neutralization[J]. Front Immunol, 2019, 10: 2968. doi:  10.3389/fimmu.2019.02968
    [11] Yang X, Su B, Zhang X, et al. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: challenges of immunological non-responders[J]. J Leukoc Biol, 2020, 107: 597-612. doi:  10.1002/JLB.4MR1019-189R
    [12] 国家卫生健康委员会. 艾滋病和艾滋病病毒感染诊断WS 293—2019[S/OL]. (2019-01-02)[2021-10-30]. http://www.nhc.gov.cn/wjw/s9491/201905/6430aa653728439c901a7340796e4723/files/84dffca4fb2c4293abb6be4d5353f924.pdf.
    [13] Panel on Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America[EB/OL]. (2021-08-18)[2021-10-30]. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Adult_OI.pdf.
    [14] 卢洪洲. 艾滋病及其相关疾病临床路径[M]. 第3版. 上海: 上海科学技术出版社, 2020.
    [15] Juniper T, Eades CP, Gil E, et al. Use of β-D-glucan in diagnosis of suspected Pneumocystis jirovecii pneumonia in adults with HIV infection[J]. Int J STD AIDS, 2021, 32: 1074-1077. doi:  10.1177/09564624211022247
    [16] McTaggart LR, Wengenack NL, Richardson SE. Valida-tion of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR[J]. J Clin Microbiol, 2012, 50: 1856-1859. doi:  10.1128/JCM.05880-11
    [17] 中华医学会感染病学分会艾滋病学组, 中华医学会热带病与寄生虫学分会艾滋病学组. HIV合并结核分枝杆菌感染诊治专家共识[J]. 中华临床感染病杂志, 2017, 10: 81-90. https://www.cnki.com.cn/Article/CJFDTOTAL-XFCR202201017.htm
    [18] World Health Organization. WHO operational handbook on tuberculosis. Module 3: diagnosis - rapid diagnostics for tuberculosis detention, 2021 update[M/OL]. (2021-07-07)[2021-10-30]. https://www.who.int/publications/i/item/9789240030589.
    [19] 乐晓琴, 陈军, 沈银忠, 等. 结核分枝杆菌/利福平耐药实时荧光定量核酸扩增检测技术诊断艾滋病患者肺结核的临床应用评价[J]. 中华传染病杂志, 2021, 39: 21-24. doi:  10.3760/cma.j.cn311365-20190729-00235
    [20] Panel on Antiretroviral Guidelines for Adults and Adoles-cents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV[EB/OL]. (2021-08-16)[2021-10-30]. https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/AdultandAdolescentGL.pdf.
    [21] European AIDS Clinical Society. EACS Guidelines(Version 10.1)[EB/OL]. (2021-07-11)[2021-10-30]. https://www.eacsociety.org/files/guidelines-10.1_30032021_1.pdf.
    [22] World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach[M/OL]. (2021-07-16)[2021-10-30]. https://www.who.int/publications/i/item/9789240031593.
    [23] World Health Organization. WHO operational handbook on tuberculosis (Module 1: prevention): tuberculosis preven-tive treatment[M/OL]. [2021-10-30]. https://apps.who.int/iris/bitstream/handle/10665/331525/9789240002906-eng.pdf.
    [24] 中华医学会热带病与寄生虫学分会艾滋病学组. 人类免疫缺陷病毒/艾滋病患者合并非结核分枝杆菌感染诊治专家共识[J]. 中华传染病杂志, 2019, 37: 129-138. doi:  10.3760/cma.j.issn.1000-6680.2019.03.001
    [25] 中国医师协会皮肤科医师分会带状疱疹专家共识工作组. 带状疱疹中国专家共识[J]. 中华皮肤科杂志, 2018, 51: 403-408. doi:  10.3760/cma.j.issn.0412-4030.2018.06.001
    [26] Wang YF, Cai JP, Wang YD, et al. Immunoassays based on Penicillium marneffei Mp1p derived from Pichia pastoris expression system for diagnosis of penicilliosis[J]. PLoS One, 2011, 6: e28796. doi:  10.1371/journal.pone.0028796
    [27] Pappas PG, Kauffman CA, Andes DR, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America[J]. Clin Infect Dis, 2016, 62: e1-e50. doi:  10.1093/cid/civ933
    [28] 中华医学会感染病学分会. 隐球菌性脑膜炎诊治专家共识[J]. 中华传染病杂志, 2018, 36: 193-199. doi:  10.3760/cma.j.issn.1000-6680.2018.04.001
    [29] Boulware DR, Meya DB, Muzoora C, et al. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis[J]. N Engl J Med, 2014, 370: 2487-2498. doi:  10.1056/NEJMoa1312884
    [30] Chang CC, Dorasamy AA, Gosnell BI, et al. Clinical and mycological predictors of cryptococcosis-associated immune reconstitution inflammatory syndrome[J]. AIDS, 2013, 27: 2089-2099. doi:  10.1097/QAD.0b013e3283614a8d
    [31] Ying RS, Le T, Cai WP, et al. Clinical epidemiology and outcome of HIV-associated talaromycosis in Guangdong, China, during 2011—2017[J]. HIV Med, 2020, 21: 729-738. doi:  10.1111/hiv.13024
    [32] Klus J, Ly VT, Chan C, et al. Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort[J]. Med Mycol, 2021, 59: 392-399. doi:  10.1093/mmy/myab005
    [33] Le T, Kinh NV, Cuc NTK, et al. A trial of itraconazole or amphotericin B for HIV-associated talaromycosis[J]. N Engl J Med, 2017, 376: 2329-2340. doi:  10.1056/NEJMoa1613306
    [34] Tun N, Mclean A, Deed X, et al. Is stopping secondary prophylaxis safe in HIV-positive talaromycosis patients? Experience from Myanmar[J]. HIV Med, 2020, 21: 671-673. doi:  10.1111/hiv.12921
    [35] 中国疾病预防控制中心性病艾滋病预防控制中心. 国家免费艾滋病抗病毒药物治疗手册[M]. 第3版. 北京: 人民卫生出版社, 2016.
    [36] Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the use of antiretroviral agents in pediatric HIV infection[EB/OL]. (2021-12-30). https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/PedARV_GL.pdf.
    [37] Dooley KE, Kaplan R, Mwelase N, et al. Dolutegravir-based antiretroviral therapy for patients coinfected with tuberculosis and human immunodeficiency virus: a multicenter, noncomparative, open-label, randomized trial[J]. Clin Infect Dis, 2020, 70: 549-556.
    [38] De Castro N, Marcy O, Chazallon C, et al. Standard dose raltegravir or efavirenz-based antiretroviral treatment for patients co-infected with HIV and tuberculosis (ANRS 12 300 Reflate TB 2): an open-label, non-inferiority, randomised, phase 3 trial[J]. Lancet Infect Dis, 2021, 21: 813-822. doi:  10.1016/S1473-3099(20)30869-0
    [39] Pozniak A, Meintjes G. Raltegravir in patients with tuberculosis[J]. Lancet Infect Dis, 2021, 21: 748-749. doi:  10.1016/S1473-3099(20)30937-3
    [40] Surial B, Béguelin C, Chave JP, et al. Switching from TDF to TAF in HIV/HBV-coinfected individuals with renal dysfunction: a prospective cohort study[J]. J Acquir Immune Defic Syndr, 2020, 85: 227-232. doi:  10.1097/QAI.0000000000002429
    [41] 李航, 张福杰, 卢洪洲, 等. HIV感染合并慢性肾脏病患者管理专家共识[J]. 中国艾滋病性病, 2017, 23: 578-581.
    [42] Eke AC, Brooks KM, Gebreyohannes RD, et al. Teno-fovir alafenamide use in pregnant and lactating women living with HIV[J]. Expert Opin Drug Metab Toxicol, 2020, 16: 333-342. doi:  10.1080/17425255.2020.1738384
    [43] De Monte A, Courjon J, Anty R, et al. Direct-acting antiviral treatment in adults infected with hepatitis C virus: reactivation of hepatitis B virus coinfection as a further challenge[J]. J Clin Virol, 2016, 78: 27-30. doi:  10.1016/j.jcv.2016.02.026
    [44] 张仁芳, 沈杨, 卢洪洲, 等. AIDS相关性淋巴瘤诊治专家共识[J]. 中国艾滋病性病, 2017, 23: 678-682. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA201708002.htm
    [45] Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission. Recommendations for the use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States[EB/OL]. (2021-12-30). https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Perinatal_GL.pdf.
    [46] 国家卫生健康委办公厅. 国家卫生健康委办公厅关于印发预防艾滋病、梅毒和乙肝母婴传播工作规范(2020年版)的通知[EB/OL]. (2020-11-12)[2021-10-30]. http://www.nhc.gov.cn/fys/s3581/202011/fc7b46b2b48b45a69bd390ae3a62d065.shtml.
    [47] U.S. Public Health Service Working Group. Updated U.S. public health service guidelines for the management of occupational exposures to HIV and recommendations for post exposure prophylaxis[EB/OL]. (2018-05-23)[2021-10-30]. https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5409a1.htm.
    [48] 中国疾病预防控制中心性病艾滋病预防控制中心. 艾滋病病毒暴露后预防技术指南(试用)[EB/OL]. (2020-11-16) [2021-10-30]. http://ncaids.chinacdc.cn/tzgggd/202011/W020201116802422550750.pdf.
    [49] 徐俊杰, 黄晓婕, 刘昕超, 等. 中国HIV暴露前预防用药专家共识[J]. 中国艾滋病性病, 2020, 26: 1265-1271.
    [50] 国家卫生计生委办公厅. 国家卫生计生委办公厅关于印发职业暴露感染艾滋病病毒处理程序规定的通知[EB/OL]. (2015-07-08)[2021-10-30]. http://www.nhc.gov.cn/jkj/s3585/201507/902caba665ac4d38ade13856d5b376f4.shtml.
    [51] 国家卫生计生委, 人力资源社会保障部, 安全监管总局, 等. 国家卫生计生委等4部门关于印发《职业病分类和目录》的通知[EB/OL]. (2013-12-23)[2021-10-30]. http://www.gov.cn/gzdt/2013-12/30/content_2557352.htm?&from=androidqq.
    [52] Nie J, Sun F, He X, et al. Tolerability and adherence of antiretroviral regimens containing long-acting Fusion inhibitor albuvirtide for HIV post-exposure prophylaxis: a cohort study in China[J]. Infect Dis Ther, 2021, 10: 2611-2623. doi:  10.1007/s40121-021-00540-5
    [53] Smith CJ, Ryom L, Weber R, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration[J]. Lancet, 2014, 384: 241-248. doi:  10.1016/S0140-6736(14)60604-8
    [54] Chen S, Han Y, Song XJ, et al. Very high baseline HIV viremia impairs efficacy of non-nucleoside reverse trans-criptase inhibitor-based ART: a long-term observation in treatment-naïve patients[J]. Infect Dis Poverty, 2020, 9: 75. doi:  10.1186/s40249-020-00700-8
    [55] Meng X, Yin K, Wang J, et al. Effect of CYP2B6 Gene Polymorphisms on Efavirenz Plasma Concentrations in Chinese Patients with HIV Infection[J]. PLoS One, 2015, 10: e0130583. doi:  10.1371/journal.pone.0130583
    [56] Guo F, Cheng X, Hsieh E, et al. Prospective plasma efavirenz concentration assessment in Chinese HIV-infected adults enrolled in a large multicentre study[J]. HIV Med, 2018, 15: 10.1111/hiv. 12607.
    [57] Xu L, Peng W, Song X, et al. Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study[J]. BMC Infect Dis, 2021, 21: 112. doi:  10.1186/s12879-021-05802-8
    [58] Shen YZH, Liu TY, Chen J, et al. Harnessing artificial intelligence to optimize long-term maintenance dosing for antiretroviral-naive adults with HIV-1 infection[J]. Adv Therap, 2020, 3: 1900114. doi:  10.1002/adtp.201900114
    [59] Chen J, Chen R, Shen Y, et al. Efficacy and safety of lower dose tenofovir disoproxil fumarate and efavirenz versus standard dose in HIV-infected, antiretroviral-naive adults: a multicentre, randomized, noninferiority trial[J]. Emerg Microbes Infect, 2020, 9: 843-850. doi:  10.1080/22221751.2020.1752609
    [60] 何小清, 沈银忠, 张仁芳, 等. 未启动抗反转录病毒治疗的人类免疫缺陷病毒/艾滋病患者发生心血管疾病的风险评估[J]. 中华传染病杂志, 2020, 38: 640-645. doi:  10.3760/cma.j.cn311365-20200510-00585
    [61] Guaraldi G, Palella FJ. Clinical implications of aging with HIV infection: perspectives and the future medical care agenda[J]. AIDS, 2017, 31: S129-S135. doi:  10.1097/QAD.0000000000001478
    [62] World Health Organization. Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection[EB/OL]. (2021-07-15)[2021-10-30]. https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-HIV-2021.1.
    [63] 中华医学会感染病学分会艾滋病丙型肝炎学组. 成人人类免疫缺陷病毒感染者新型冠状病毒疫苗接种专家建议[J]. 中华内科杂志, 2021, 60: 615-618. doi:  10.3760/cma.j.cn112138.20210403-00259
    • Relative Articles(0)
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (4332) PDF downloads(4039) Cited by()
    Proportional views
    Related
    Links: National Health Commission of the People's Republic of China Chinese Academy of Medical Sciences(CAMS) AMLC Check CNKI Database CNKI Term Online Chinese General Practice
    Address：Room 302,Third Floor,Building 7, No. 1 Shuaifuyuan, Wangfujing, Dongcheng District, Beijing 100730, China
    Tel：010-69154261/4262
    E - mail：medj@pumch.cn
    mjpumch@126.com
    Copyright of website：Editorial Office of Medical Journal of Peking Union Medical College Hospital

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return